Seeheim-Jugenheim, Germany

Harald Krempel

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harald Krempel. Retrieved from https://idiyas.com/inventor/harald-krempel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Harald Krempel

Introduction

Harald Krempel is a notable inventor based in Seeheim-Jugenheim, Germany. He has made significant contributions to the field of pharmaceuticals through his innovative use of inorganic aerogels. His work has the potential to enhance the effectiveness of pharmaceutical active compounds and preparations.

Latest Patents

Krempel holds a patent for the "Use of inorganic aerogels in pharmacy." This invention relates to the application of inorganic aerogels as an auxiliary and/or excipient for pharmaceutical active compounds and/or preparations. His innovative approach aims to improve the delivery and efficacy of medications.

Career Highlights

Krempel is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work there has allowed him to explore and develop new applications for materials that can significantly impact drug formulation and delivery.

Collaborations

Throughout his career, Krempel has collaborated with esteemed colleagues such as Fritz Schwertfeger and Andreas Zimmermann. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Harald Krempel's contributions to the field of pharmacy through his innovative use of inorganic aerogels exemplify the importance of research and development in enhancing pharmaceutical applications. His work continues to inspire advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…